170 related articles for article (PubMed ID: 36374823)
1. Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis.
Chazal T; Pegoraro F; Manari G; Bettiol A; Maniscalco V; Gelain E; Charlotte F; Mazor RD; Renard-Penna R; Amoura Z; Cohen-Aubart F; Haroche J; Izzedine H; Vaglio A
Kidney Int; 2023 Jan; 103(1):177-186. PubMed ID: 36374823
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults.
Cao XX; Sun J; Li J; Zhong DR; Niu N; Duan MH; Liang ZY; Zhou DB
Ann Hematol; 2016 Apr; 95(5):745-50. PubMed ID: 26858028
[TBL] [Abstract][Full Text] [Related]
3. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
[TBL] [Abstract][Full Text] [Related]
4. Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAF
Nikpanah M; Kim L; Mirmomen SM; Symons R; Papageorgiou I; Gahl WA; O'Brien K; Estrada-Veras JI; Malayeri AA
Eur Radiol; 2018 Sep; 28(9):3751-3759. PubMed ID: 29556768
[TBL] [Abstract][Full Text] [Related]
5. Hypoalphalipoproteinemia and BRAF
Cohen-Aubart F; Guerin M; Poupel L; Cluzel P; Saint-Charles F; Charlotte F; Arsafi Y; Emile JF; Frisdal E; Le Goff C; Donadieu J; Amoura Z; Lesnik P; Haroche J; Le Goff W
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1913-1925. PubMed ID: 29930009
[TBL] [Abstract][Full Text] [Related]
6. Urinary involvement in Erdheim-Chester disease: computed tomography imaging findings.
Wu Z; Jiang GL; Tang Y; Jiang C; Sun LL; Li N; Jin ZY; Sun H
Abdom Radiol (NY); 2021 Sep; 46(9):4324-4331. PubMed ID: 33970298
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
[TBL] [Abstract][Full Text] [Related]
8. Urologic manifestations of Erdheim-Chester disease.
Yelfimov DA; Lightner DJ; Tollefson MK
Urology; 2014 Jul; 84(1):218-21. PubMed ID: 24788188
[TBL] [Abstract][Full Text] [Related]
9. Erdheim-Chester disease.
Haroche J; Cohen-Aubart F; Amoura Z
Blood; 2020 Apr; 135(16):1311-1318. PubMed ID: 32107533
[TBL] [Abstract][Full Text] [Related]
10. Erdheim-Chester disease.
Campochiaro C; Tomelleri A; Cavalli G; Berti A; Dagna L
Eur J Intern Med; 2015 May; 26(4):223-9. PubMed ID: 25865950
[TBL] [Abstract][Full Text] [Related]
11. [Erdheim-Chester disease with cardiac involvement. Case report].
Latyshev VD; Mershina EА; Kostina IE; Sinitsyn VЕ; Lukina EA
Ter Arkh; 2022 Aug; 94(7):897-902. PubMed ID: 36286949
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, patterns and outcomes of cardiac involvement in Erdheim-Chester disease.
Azoulay LD; Bravetti M; Cohen-Aubart F; Emile JF; Seilhean D; Plu I; Charlotte F; Waintraub X; Carrat F; Amoura Z; Cluzel P; Haroche J
Eur Heart J; 2023 Jul; 44(26):2376-2385. PubMed ID: 36545799
[TBL] [Abstract][Full Text] [Related]
13. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis.
Hao X; Feng R; Bi Y; Liu Y; Li C; Lu T; Tian Y
J Neurosurg Pediatr; 2018 Sep; 23(1):48-53. PubMed ID: 30265230
[TBL] [Abstract][Full Text] [Related]
14. Erdheim-Chester disease.
Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
Curr Rheumatol Rep; 2014 Apr; 16(4):412. PubMed ID: 24532298
[TBL] [Abstract][Full Text] [Related]
15. Erdheim Chester disease in a patient with Burkitt lymphoma: a case report and review of literature.
Sakr HI; Buckley K; Baiocchi R; Zhao WJ; Hemminger JA
Diagn Pathol; 2018 Nov; 13(1):94. PubMed ID: 30474563
[TBL] [Abstract][Full Text] [Related]
16. Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.
Diamond EL; Subbiah V; Lockhart AC; Blay JY; Puzanov I; Chau I; Raje NS; Wolf J; Erinjeri JP; Torrisi J; Lacouture M; Elez E; Martínez-Valle F; Durham B; Arcila ME; Ulaner G; Abdel-Wahab O; Pitcher B; Makrutzki M; Riehl T; Baselga J; Hyman DM
JAMA Oncol; 2018 Mar; 4(3):384-388. PubMed ID: 29188284
[TBL] [Abstract][Full Text] [Related]
17. Does the BRAF(V600E) mutation herald a new treatment era for Erdheim-Chester disease? A case-based review of a rare and difficult to diagnose disorder.
Bosco J; Allende A; Varikatt W; Lee R; Stewart GJ
Intern Med J; 2015 Mar; 45(3):348-51. PubMed ID: 25735579
[TBL] [Abstract][Full Text] [Related]
18. A long-term survival case of Erdheim-Chester disease on maintenance hemodialysis.
Konishi R; Morinishi T; Takaori K; Iwamoto Y; Kondo M; Maeda S
CEN Case Rep; 2022 Aug; 11(3):289-294. PubMed ID: 34978674
[TBL] [Abstract][Full Text] [Related]
19. Case Report of Erdheim-Chester Disease Successfully Treated with Pegylated Interferon: A Single-Center Experience.
Lim Y; Yoon SE; Cho J; Kim D; Jung CW
Cancer Res Treat; 2023 Jul; 55(3):1053-1057. PubMed ID: 36701845
[TBL] [Abstract][Full Text] [Related]
20. A case of Erdheim-Chester disease with spinal cord compression and sphenoid sinus involvement.
Bunaux K; Sevestre H; Emile JF; Capel C; Chenin L; Peltier J
Neurochirurgie; 2018 Dec; 64(6):439-441. PubMed ID: 30274919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
